Nighthawk Biosciences Inc (NHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,132 | 40,597 | 47,160 | 55,239 | 38,245 |
| Marketable Securities | 4,996 | 4,991 | N/A | N/A | 10,000 |
| Receivables | 23,142 | 22,684 | 24,393 | 26,399 | 26,553 |
| Income taxes - deferred | 267 | N/A | 855 | 615 | 294 |
| TOTAL | $82,579 | $75,176 | $78,639 | $85,079 | $79,392 |
| Non-Current Assets | |||||
| PPE Net | 11,239 | 10,915 | 10,528 | 11,018 | 11,669 |
| Intangibles | 76,009 | 77,747 | 148,334 | 150,324 | 152,380 |
| Other Non-Current Assets | 22,890 | 22,556 | 7,648 | 5,746 | 5,563 |
| TOTAL | $110,138 | $111,218 | $166,510 | $167,088 | $169,612 |
| Total Assets | $192,717 | $186,394 | $245,149 | $252,167 | $249,004 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 955 | 955 | 955 | 1,000 | 1,000 |
| Accounts payable and accrued liabilities | 7,111 | 5,842 | 6,327 | 6,063 | 6,895 |
| Accrued Expenses | 6,999 | 6,102 | 7,400 | 7,075 | 8,477 |
| TOTAL | $15,065 | $12,899 | $14,682 | $14,138 | $16,372 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,667 | 92,906 | 93,145 | 97,750 | 98,000 |
| Other Non-Current Liabilities | 6,573 | 7,185 | 7,555 | 7,044 | 6,594 |
| TOTAL | $99,240 | $100,091 | $100,700 | $104,794 | $104,594 |
| Total Liabilities | $114,305 | $112,990 | $115,382 | $118,932 | $120,966 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,503 | 26,483 | 26,559 | 28,606 | 28,542 |
| Common Shares | 27 | 26 | 28 | 29 | 29 |
| Retained earnings | -154,035 | -156,129 | -103,516 | -106,173 | -109,456 |
| Other shareholders' equity | -1,103 | -3,342 | -4,174 | -1,628 | -1,692 |
| TOTAL | $78,412 | $73,404 | $129,767 | $133,235 | $128,038 |
| Total Liabilities And Equity | $192,717 | $186,394 | $245,149 | $252,167 | $249,004 |